Invesco Ltd. Curis Inc Transaction History

Invesco Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.71 - $2.43 $26,278 - $89,939	-37,012 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.31 - $5.13 $316 - $702	137 Added 0.37%	37,012 $88,000
Q4 2021 Feb 14, 2022	SELL	$4.45 - $8.09 $59,905 - $108,907	-13,462 Reduced 26.74%	36,875 $176,000
Q3 2021 Nov 15, 2021	BUY	$6.94 - $8.85 $73,564 - $93,810	10,600 Added 26.68%	50,337 $394,000
Q2 2021 Aug 17, 2021	SELL	$7.45 - $16.27 $13.2 Million - $28.9 Million	-1,773,592 Reduced 97.81%	39,737 $321,000
Q1 2021 May 17, 2021	BUY	$8.78 - $12.8 $15.9 Million - $23.2 Million	1,813,329 New	1,813,329 $20.5 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $403M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.